May 10 Merck & Co said on Wednesday that U.S. health regulators approved its Keytruda in combination with chemotherapy for previously untreated advanced lung cancer, solidifying the drugmaker's lead position in the field of medicines that help the immune system fight cancer.
Lung cancer is by far the largest oncology market and the approval significantly expands the number of patients available for Keytruda therapy. (Reporting by Bill Berkrot; Editing by James Dalgleish)
UPDATE 1-Germany plans new emissions testing body after VW scandal
BERLIN, June 27 The German transport ministry announced plans on Tuesday to set up a new institute to test vehicle emissions to try to restore consumer confidence after the Volkswagen scandal.
EU antitrust chief to speak at 1000 GMT on competition case
BRUSSELS, June 27 European Competition Commissioner Margrethe Vestager will hold a news conference on a competition case at 1200 CET (10 GMT), the European Commission said on Tuesday, with sources saying she would announce her verdict on a case concerning Alphabet's Google.